Sandostatin Lar 30Mg Injection 1

Sandostatin Lar 30mg Injection 1 may interact with the following medicines:

• Antidiabetic agents (e.g., insulin, sulfonylureas): Risk of both hypoglycaemia and hyperglycaemia; glucose monitoring and dose adjustment may be necessary.
• Immunosuppressants (e.g., cyclosporine): May reduce cyclosporine absorption and effectiveness; monitoring of medicine levels is required.
• Beta-blockers and calcium channel blockers (e.g., atenolol, verapamil): May increase the risk of bradycardia and conduction abnormalities; cardiac monitoring is advised.
• Dopamine agonists (e.g., bromocriptine): Concomitant use may alter hormone control and requires careful dose regulation.

Sandostatin Lar 30mg Injection 1 may interact with the following conditions:

• Cholelithiasis (gallstones): Risk is increased with long-term therapy; routine ultrasound monitoring is recommended.
• Glucose metabolism disorders: May cause hypo- or hyperglycaemia; regular monitoring of blood sugar is required.
• Thyroid dysfunction: May reduce thyroid hormone levels, leading to hypothyroidism; thyroid function tests should be monitored periodically.
• Cardiac disorders (e.g., bradycardia, arrhythmias): Octreotide may worsen pre-existing cardiac conditions; patients require careful monitoring.
   

The exact dose and interval of Sandostatin Lar 30mg Injection 1 will be decided by your doctor depending on your underlying condition and response to treatment. Dose adjustments may be required in patients with liver or kidney impairment.

An overdose is highly unlikely for this medication as it is administered by a healthcare professional.
 

If you miss an injection appointment, contact your doctor or healthcare provider promptly to reschedule. Do not take a double dose to make up for the missed injection.